Kevin Pelphrey is Harrison-Wood Professor of Neurology at the University of Virginia in Charlottesville.
Kevin Pelphrey
Harrison-Wood Professor of Neurology
University of Virginia
From this contributor
Why concern about facial recognition from brain scans is overblown
Can brain scans, in the wrong hands, compromise research participants' identity? The risk is minimal.
Why concern about facial recognition from brain scans is overblown
By
Kevin Pelphrey
18 February 2020 | 5 min read
What teenagers can teach scientists about autism
Examining the teenage years presents a major opportunity for understanding and treating autism.
What teenagers can teach scientists about autism
By
Kevin Pelphrey
27 February 2018 | 5 min read
Technology can curb social exclusion of children with autism
Apps, robots and brain imaging can help children with autism improve their social skills and connect with other people.
Technology can curb social exclusion of children with autism
By
Kevin Pelphrey
10 January 2017 | 6 min read
Reckless report exaggerates flaws in brain scan software
A bug in brain imaging software casts doubt on the results of some autism studies, but it’s way too soon to write off the powerful imaging technique.
Reckless report exaggerates flaws in brain scan software
By
Kevin Pelphrey
16 August 2016 | 1 min read
How dining out with my daughter inspired my autism studies
Restaurants can be stressful for my daughter Frances, who has autism, but her difficulties led me to try to better understand and treat her type of situational anxiety.
How dining out with my daughter inspired my autism studies
By
Kevin Pelphrey
12 May 2016 | 7 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read